Skip to main content

Table 3 Sperm survival test in men with and without metabolic syndrome

From: Impact of metabolic syndrome on the viability of human spermatozoa: a cross-sectional descriptive study in men from infertile couples

SST Total
(n = 195)
Metabolic syndrome P-valuea
MetS
(n = 47)
Non-MetS
(n = 148)
PR motility (%)
 PR-0 h 76.03 ± 10.52 76.53 ± 9.65 75.87 ± 10.81 0.71
 PR-24 h 30.99 ± 15.80 28.81 ± 14.96 31.69 ± 16.05 0.28
Viability (%)
 Viable-0 h 86.78 ± 6.91 86.53 ± 7.04 86.86 ± 6.89 0.77
 Viable-24 h 54.98 ± 17.33 53.15 ± 17.24 55.57 ± 17.38 0.41
Result of SST [n(%)]
 Normal 82 (42.1%) 13 (27.7%) 69 (46.6%) 0.02
 Abnormal 113 (57.9%) 34 (72.3%) 79 (53.4%)
 SMI-24 h (%) 40.20 ± 18.60 36.87 ± 16.47 41.24 ± 19.16 0.16
 SVI-24 h (%) 62.68 ± 17.34 60.79 ± 17.01 63.28 ± 17.57 0.39
  1. PR progressive; SMI sperm motility index; SST sperm survival test; SVI sperm vitality index
  2. Sperm parameters were assessed after prepared by gradient density centrifugation
  3. Values were expressed as mean ± SD and the percentage
  4. a Comparison was performed between men with and without MetS using the independent-samples t test and the chi-square test